Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00020735
Status:
COMPLETED
Last Update Posted:
2015-12-02
First Post:
2001-07-11
Brief Title:
Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer
Sponsor:
Joel Nelson MD
Organization:
University of Pittsburgh
Organization Data
Organization:
University of Pittsburgh
Class:
OTHER
Study ID:
PCI-00-105
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Joel Nelson MD
Lead Sponsor Class:
OTHER
Responsible Party:
Joel Nelson MD
Responsible Party Title:
Professor and Chairman Department of Urology University of Pittsburgh School of Medicine Chief Division of Surgery UPMC Shadyside Hospital
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Pittsburgh
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |